TC
GILD icon

TownSquare Capital’s Gilead Sciences GILD Stock Holding History

TownSquare Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$969K Buy
6,955
+198
+3% +$27.7K 0.22% 96
2025
Q4 		$829K Sell
6,757
-394
-6% -$47.9K 0.19% 108
2025
Q3 		$794K Sell
7,151
-5,145
-42% -$585K 0.12% 158
2025
Q2 		$1.36M Sell
12,296
-122,357
-91% -$13M 0.13% 147
2025
Q1 		$15.1M Buy
134,653
+1,000
+0.7% +$103K 0.16% 115
2024
Q4 		$12.3M Sell
133,653
-1,311
-1% -$118K 0.14% 131
2024
Q3 		$11.3M Buy
134,964
+16,996
+14% +$1.3M 0.14% 143
2024
Q2 		$8.09M Buy
117,968
+723
+0.6% +$48.2K 0.11% 181
2024
Q1 		$8.59M Sell
117,245
-20,535
-15% -$1.58M 0.13% 159
2023
Q4 		$11.2M Buy
137,780
+62,052
+82% +$4.83M 0.19% 105
2023
Q3 		$5.68M Buy
75,728
+6,294
+9% +$484K 0.1% 186
2023
Q2 		$5.35M Buy
69,434
+5,228
+8% +$417K 0.1% 199
2023
Q1 		$5.33M Buy
64,206
+1,981
+3% +$164K 0.12% 162
2022
Q4 		$5.34M Sell
62,225
-12,390
-17% -$981K 0.13% 147
2022
Q3 		$4.6M Buy
74,615
+892
+1% +$56.2K 0.13% 137
2022
Q2 		$4.56M Buy
73,723
+2,603
+4% +$161K 0.13% 145
2022
Q1 		$4.23M Buy
71,120
+6,203
+10% +$397K 0.11% 174
2021
Q4 		$4.71M Sell
64,917
-12,774
-16% -$880K 0.12% 149
2021
Q3 		$5.43M Buy
77,691
+7,440
+11% +$523K 0.16% 119
2021
Q2 		$4.81M Buy
70,251
+9,201
+15% +$614K 0.16% 116
2021
Q1 		$3.95M Buy
61,050
+14,824
+32% +$956K 0.15% 121
2020
Q4 		$2.69M Buy
46,226
+14,924
+48% +$901K 0.12% 151
2020
Q3 		$1.96M Buy
31,302
+2,414
+8% +$167K 0.11% 150
2020
Q2 		$2.21M Buy
28,888
+25,617
+783% +$1.96M 0.15% 120
2020
Q1 		$262K Sell
3,271
-353
-10% -$24.4K 0.02% 354
2019
Q4 		$235K Sell
3,624
-35
-1% -$2.28K 0.02% 397
2019
Q3 		$234K Sell
3,659
-281
-7% -$18.4K 0.02% 434
2019
Q2 		$256K Sell
3,940
-11,775
-75% -$775K 0.02% 395
2019
Q1 		$1.02M Buy
15,715
+12,039
+328% +$800K 0.08% 183
2018
Q4 		$249K Buy
+3,676
New +$257K 0.03% 324

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

TownSquare Capital's GILD Position: Q1 2026 in Review

TownSquare Capital increased its Gilead Sciences (GILD) stake by 2.9% in Q1 2026, buying an estimated $27.7K and bringing the position to 6,955 shares worth $969K. The position accounts for 0.22% of the portfolio, ranked #96.

TownSquare Capital first reported a position in GILD in Q4 2018 and has held it in 30 quarters since. The position peaked at $15.1M in Q1 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • TownSquare Capital held 6,955 shares of Gilead Sciences worth $969K as of Q1 2026.
  • TownSquare Capital bought 198 Gilead Sciences shares in Q1 2026, an estimated $27.7K.
  • Gilead Sciences made up 0.22% of TownSquare Capital's portfolio in Q1 2026, its #96 holding.
  • TownSquare Capital first reported a position in Gilead Sciences in Q4 2018 and has held it in 30 quarters since.
  • TownSquare Capital's Gilead Sciences position peaked at $15.1M in Q1 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on TownSquare Capital's 13F filing for Q1 2026, filed 13 May 2026.